Ardelyx (ARDX) Non-Current Assets (2013 - 2026)
Ardelyx (ARDX) posted Non-Current Assets of $122.6 million for Q1 2026, up 2.81% on a QoQ basis from $119.3 million in Q4 2025, and up 25.78% year-over-year from $97.5 million in Q1 2025.
Ardelyx (ARDX) Non-Current Assets (2013 - 2026) Analysis & Trends
Ardelyx's Non-Current Assets history runs 14 years deep, the most recent figure standing at $122.6 million for Q1 2026.
- Quarterly Non-Current Assets rose 25.78% year-over-year to $122.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $475.3 million (up 39.37% YoY) and the FY2025 annual result came in at $119.3 million, up 50.42% from the prior year.
- Non-Current Assets was $122.6 million for Q1 2026 at Ardelyx, up from $119.3 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $122.6 million in Q1 2026 and bottomed at $15.2 million in Q1 2022.
- A 5-year average of $70.2 million and a median of $79.3 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets dropped 5.34% — and 2023, when it jumped 229.13%.
- Ardelyx's Non-Current Assets stood at $36.5 million in 2022, then soared by 41.15% to $51.5 million in 2023, then soared by 54.08% to $79.3 million in 2024, then surged by 50.42% to $119.3 million in 2025, then gained by 2.81% to $122.6 million in 2026.
- Business Quant data shows ARDX's Non-Current Assets at $122.6 million in Q1 2026, $119.3 million in Q4 2025, and $118.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Ardelyx | 1.26 Bn | 1.02 Bn | 89.66 Mn | 122.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 122.64 Mn |
| Dec 31, 2025 | 119.29 Mn |
| Sep 30, 2025 | 118.19 Mn |
| Jun 30, 2025 | 115.20 Mn |
| Mar 31, 2025 | 97.50 Mn |
| Dec 31, 2024 | 79.30 Mn |
| Sep 30, 2024 | 83.77 Mn |
| Jun 30, 2024 | 80.47 Mn |
| Mar 31, 2024 | 84.44 Mn |
| Dec 31, 2023 | 51.47 Mn |
| Sep 30, 2023 | 48.16 Mn |
| Jun 30, 2023 | 49.09 Mn |
| Mar 31, 2023 | 49.97 Mn |
| Dec 31, 2022 | 36.46 Mn |
| Sep 30, 2022 | 24.80 Mn |
| Jun 30, 2022 | 17.50 Mn |
| Mar 31, 2022 | 15.18 Mn |
| Dec 31, 2021 | 16.26 Mn |
| Sep 30, 2021 | 17.47 Mn |
| Jun 30, 2021 | 18.49 Mn |